Ravi Jagasia

This inventor holds 17 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 11 EPO patents. Top assignees: Hoffmann-La Roche Inc., Roche Innovation Center Copenhagen A/s. Active years: 2016-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ravi Jagasia. Retrieved from https://idiyas.com/inventor/ravi-jagasia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 (Patent Applications = 2)

% Patents Active = 41.2

CIPO Patents = 1 (Patent Applications = 7)

EPO Patents = 11 (Patent Applications = 12)

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 23(Granted Patents)

Location History:

Lorrach, DE (2016)
Loerrach, DE (2016 - 2017)
Basel, CH (2019 - 2023)

Company Filing History:

16 out of 5,026

Hoffmann-La Roche Inc.

patents

1 out of 46

Roche Innovation Center Copenhagen A/s

patents

Years Active: 2016-2023

Loading Chart...

17 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11852627 - Oligonucleotides for inducing paternal UBE3A expression (2023-12-26),

2. 11320421 - Oligonucleotides for inducing paternal UBE3A expression (2022-05-03),

3. 10739332 - Oligonucleotides for inducing paternal UBE3A expression (2020-08-11),

4. 10718753 - Oligonucleotides for inducing paternal UBE3A expression (2020-07-21),

5. 10494633 - Oligonucleotides for inducing paternal UBE3A expression (2019-12-03),

6. 9714239 - N-phenyl-lactam derivatives capable of stimulating neurogenesis and their use in the treatment of neurological disorders (2017-07-25),

7. 9688675 - 1,7-naphthyridine derivatives (2017-06-27),

8. 9670206 - Pyrido[4,3-B]pyrazine-2-carboxamides as neurogenic agents for the treatment of neurodegenerative disorders (2017-06-06),

9. 9657014 - Substituted 1,6-naphthyridines (2017-05-23),

10. 9586966 - Piperazino[1,2-a]indol-1-ones and [1,4]diazepino[1,2-a]indol-one (2017-03-07),

11. 9586903 - Isoquinoline derivatives (2017-03-07),

12. 9464049 - Indole-carboxamides (2016-10-11),

13. 9440962 - Benzisoxazoles (2016-09-13),

14. 9365550 - Benzimidazoles as CNS active agents (2016-06-14),

15. 9315502 - Imidazopyridine derivatives (2016-04-19),

Title: Ravi Jagasia - Innovative Inventor from Loerrach

Introduction: Ravi Jagasia is a talented inventor based in Loerrach, Germany, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Ravi Jagasia holds several patents in the areas of artificial intelligence, renewable energy, and sustainable technologies, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Ravi Jagasia has successfully developed cutting-edge solutions that have revolutionized various industries. His innovative approach has earned him recognition as a leading figure in the world of inventors.

Collaborations: Throughout his career, Ravi Jagasia has collaborated with top research institutions, universities, and companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has led to the successful implementation of several groundbreaking projects.

Conclusion: Ravi Jagasia's dedication to innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors. His impact on the world of technology is undeniable, and his legacy will undoubtedly endure for years to come.

Profile summary based on public USPTO records.